Search
brivaracetam (Briviact)
Indications:
- adjunctive therapy for partial seizures (focal epilepsy) in patients >= 16 years [1]
Adverse effects:
- most common
- drowsiness
- dizziness
- fatigue
- nausea/vomiting
- serious
- suicidal ideation
- agitation
- depression
- aggression
- panic attacks
- rare
- anaphylaxis
Laboratory:
- brivaracetam in serum/plasma
Notes:
- marketed by UCB, Inc. of Smyrna, Georgia.
Interactions
drug adverse effects of anticonvulsants
monitor with anticonvulsants
General
anticonvulsant
References
- FDA News Release. February 19, 2016
FDA approves Briviact to treat partial onset seizures
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm